Varicella-zoster virus

Clinical trials for Varicella-zoster virus explained in plain language.

Never miss a new study

Get alerted when new Varicella-zoster virus trials appear

Sign up with your email to follow new studies for Varicella-zoster virus, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2

Can delaying the second shingles shot boost protection for people on MS drugs?

Prevention Not yet recruiting

People with multiple sclerosis or neuromyelitis optica spectrum disorder who take anti-CD20 drugs have a higher risk of shingles. The shingles vaccine is recommended for them, but the drug may weaken its effect. This trial compares two dosing schedules: one gives the second shot …

Matched conditions: VARICELLA-ZOSTER VIRUS

Phase 4 • Sponsor: University Hospital, Toulouse • Aim: Prevention

Last updated Sep 16, 2026 00:00 UTC

Varicella-zoster virus

Get alerted when new Varicella-zoster virus trials appear

Can delaying the second shingles shot boost protection for people on MS drugs?